Sfoglia per Autore
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI]
1992-01-01 Sarmati, L; Parisi, S; Armignacco, O; Sarrecchia, C; Antonucci, G; Ercoli, L; Andreoni, M; Rocchi, G
Therapy and prevention of infective endocarditis
1994-01-01 Rocchi, G; Sordillo, P; Sarrecchia, C; Sanguigni, V
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms.
2000-01-01 Bergamini, A; Bolacchi, F; Bongiovanni, B; Cepparulo, M; Ventura, L; Capozzi, M; Sarrecchia, C; Rocchi, G
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients
2000-01-01 Testore, Gp; Uccella, I; Sarrecchia, C; Mattei, A; Impagliazzo, A; Sordillo, P; Andreoni, M
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome.
2001-01-01 Testore, Gp; Falco, F; Sarrecchia, C; Sordillo, P; Bontempo, G; Andreoni, M
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon
2001-01-01 Sarrecchia, C; Niutta, P; Testore, Gp; Sordillo, P; Proietti, F; Andreoni, M
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb
2005-01-01 Sarrecchia, C; Cappelli, A; Aiello, P
Multidrug resistance after lamivudine therapy for chronic hepatitis B
2009-01-01 Sarrecchia, C; Volpi, A; Sordillo, P; Andreoni, M
Aciclovir, herpes viruses and HIV: a never-ending story
2009-01-01 Volpi, A; Sarrecchia, C; Sordillo, P
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection
2011-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance.
2011-01-01 Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
2011-01-01 Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance
2011-06-15 Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection
2011-11-09 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; CECCHERINI SILBERSTEIN, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, Cf
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy
2011-11-23 Ceccarelli, L; Salpini, R; Sarmati, L; Svicher, V; Bertoli, A; Sordillo, P; Ricciardi, A; Perno, Cf; Andreoni, M; Sarrecchia, C
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen
2012-01-01 Cento, V; Van Hemert, F; Di Maio, V; Salpini, R; Mirabelli, C; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; De Sanctis, G; Marino, N; Mazzotta, F; Cappiello, G; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Perno, Cf; Svicher, V
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors
2012-01-01 Cento, V; Mirabelli, C; Salpini, R; Dimonte, S; Artese, A; Costa, G; Mercurio, F; Svicher, V; Parrotta, L; Bertoli, A; Ciotti, M; Di Paolo, D; Sarrecchia, C; Andreoni, M; Alcaro, S; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.
2012-01-01 Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Van Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; CECCHERINI SILBERSTEIN, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, Cf
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
2013-01-01 Salpini, R; Alteri, C; Cento, V; Pollicita, M; Micheli, V; Gubertini, G; De Sanctis, G; Visca, M; Romano, S; Sarrecchia, C; Andreoni, M; Angelico, M; Parruti, G; Svicher, V; Perno, Cf
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice
2013-06-01 Salpini, R; Alteri, C; Cento, V; Pollicita, M; Micheli, V; Gubertini, G; De Sanctis, G; Visca, M; Romano, S; Sarrecchia, C; Andreoni, M; Angelico, M; Parruti, G; Svicher, V; Perno, Cf
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-1992 | HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] | Sarmati, L; Parisi, S; Armignacco, O; Sarrecchia, C; Antonucci, G; Ercoli, L; Andreoni, M; Rocchi, G | Intervento a convegno | |
| 1-gen-1994 | Therapy and prevention of infective endocarditis | Rocchi, G; Sordillo, P; Sarrecchia, C; Sanguigni, V | Articolo su rivista | |
| 1-gen-2000 | Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. | Bergamini, A; Bolacchi, F; Bongiovanni, B; Cepparulo, M; Ventura, L; Capozzi, M; Sarrecchia, C; Rocchi, G | Articolo su rivista | |
| 1-gen-2000 | Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients | Testore, Gp; Uccella, I; Sarrecchia, C; Mattei, A; Impagliazzo, A; Sordillo, P; Andreoni, M | Articolo su rivista | |
| 1-gen-2001 | Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. | Testore, Gp; Falco, F; Sarrecchia, C; Sordillo, P; Bontempo, G; Andreoni, M | Articolo su rivista | |
| 1-gen-2001 | Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon | Sarrecchia, C; Niutta, P; Testore, Gp; Sordillo, P; Proietti, F; Andreoni, M | Articolo su rivista | |
| 1-gen-2005 | HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb | Sarrecchia, C; Cappelli, A; Aiello, P | Articolo su rivista | |
| 1-gen-2009 | Multidrug resistance after lamivudine therapy for chronic hepatitis B | Sarrecchia, C; Volpi, A; Sordillo, P; Andreoni, M | Articolo su rivista | |
| 1-gen-2009 | Aciclovir, herpes viruses and HIV: a never-ending story | Volpi, A; Sarrecchia, C; Sordillo, P | Articolo su rivista | |
| 1-gen-2011 | Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Chen, M; Salpini, R; Chang, L; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gubertini, G; Marino, N; Mazzotta, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; CECCHERINI SILBERSTEIN, F; Zhan, J; Verheyen, J; Cappiello, G; Perno, Cf | Intervento a convegno | |
| 1-gen-2011 | Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. | Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M | Articolo su rivista | |
| 1-gen-2011 | Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. | Salpini, R; Svicher, V; Cento, V; Gori, C; Bertoli, A; Scopelliti, F; Micheli, V; Cappiello, T; Spanò, A; Rizzardini, G; De Sanctis, G; Sarrecchia, C; Angelico, M; Perno, Cf | Articolo su rivista | |
| 15-giu-2011 | Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance | Sarrecchia, C; Svicher, V; Volpi, A; Salpini, R; Ceccarelli, L; Sordillo, P; Bertoli, A; Perno, Cf; Andreoni, M | Articolo su rivista | |
| 9-nov-2011 | Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; CECCHERINI SILBERSTEIN, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, Cf | Articolo su rivista | |
| 23-nov-2011 | Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy | Ceccarelli, L; Salpini, R; Sarmati, L; Svicher, V; Bertoli, A; Sordillo, P; Ricciardi, A; Perno, Cf; Andreoni, M; Sarrecchia, C | Articolo su rivista | |
| 1-gen-2012 | Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen | Cento, V; Van Hemert, F; Di Maio, V; Salpini, R; Mirabelli, C; Bertoli, A; Gori, C; Micheli, V; Gubertini, G; Longo, R; Romano, S; Visca, M; De Sanctis, G; Marino, N; Mazzotta, F; Cappiello, G; Sarrecchia, C; CECCHERINI SILBERSTEIN, F; Andreoni, M; Angelico, M; Perno, Cf; Svicher, V | Intervento a convegno | |
| 1-gen-2012 | HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors | Cento, V; Mirabelli, C; Salpini, R; Dimonte, S; Artese, A; Costa, G; Mercurio, F; Svicher, V; Parrotta, L; Bertoli, A; Ciotti, M; Di Paolo, D; Sarrecchia, C; Andreoni, M; Alcaro, S; Angelico, M; Perno, Cf; CECCHERINI SILBERSTEIN, F | Articolo su rivista | |
| 1-gen-2012 | Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. | Svicher, V; Cento, V; Bernassola, M; Neumann Fraune, M; Van Hemert, F; Chen, M; Salpini, R; Liu, C; Longo, R; Visca, M; Romano, S; Micheli, V; Bertoli, A; Gori, C; CECCHERINI SILBERSTEIN, F; Sarrecchia, C; Andreoni, M; Angelico, M; Ursitti, A; Spanò, A; Zhang, J; Verheyen, J; Cappiello, G; Perno, Cf | Articolo su rivista | |
| 1-gen-2013 | Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. | Salpini, R; Alteri, C; Cento, V; Pollicita, M; Micheli, V; Gubertini, G; De Sanctis, G; Visca, M; Romano, S; Sarrecchia, C; Andreoni, M; Angelico, M; Parruti, G; Svicher, V; Perno, Cf | Articolo su rivista | |
| 1-giu-2013 | Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice | Salpini, R; Alteri, C; Cento, V; Pollicita, M; Micheli, V; Gubertini, G; De Sanctis, G; Visca, M; Romano, S; Sarrecchia, C; Andreoni, M; Angelico, M; Parruti, G; Svicher, V; Perno, Cf | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile